Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
<p>Abstract</p> <p>Background</p> <p>Currently, Atypical Teratoid Rhabdoid Tumor (AT/RT) constitutes one of the most difficult to treat malignancies in pediatrics. Hence, new knowledge of potential targets for therapeutics and the development of novel treatment approach...
Main Authors: | Jayanthan Aarthi, Bernoux Delphine, Bose Pinaki, Riabowol Karl, Narendran Aru |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/11/1/44 |
Similar Items
-
Aurora kinases as druggable targets in pediatric leukemia: heterogeneity in target modulation activities and cytotoxicity by diverse novel therapeutic agents.
by: Aarthi Jayanthan, et al.
Published: (2014-01-01) -
Survivin as a Preferential Target for Cancer Therapy
by: Mahsa Mobahat, et al.
Published: (2014-02-01) -
Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
by: Davide Saronni, et al.
Published: (2022-09-01) -
Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers
by: Shaelene Standing, et al.
Published: (2022-11-01) -
Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy
by: Subhanwita Sarkar, et al.
Published: (2024-02-01)